E
ENDRA Life Sciences Inc. (NDRA)
NCM – Real Time Price. Currency in USD
4.99
+0.69 (16.05%)
At close: Jun 26, 2026, 4:00 PM EDT
4.95
-0.04 (-0.80%)
After-hours: Jun 26, 2026, 5:49 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
4.99
+0.69 (16.05%)
At close: Jun 26, 2026, 4:00 PM EDT
4.95
-0.04 (-0.80%)
After-hours: Jun 26, 2026, 5:49 PM EDT
No Data
There are no news for this stock.
Total debt $461.2K significantly exceeds cash reserves ($356.5K), raising financial stability concerns
Total current liabilities $835.4K surpass Total current assets $536.7K, signaling liquidity issues
Debt-to-equity ratio (0.3) is well below the industry average (-0.1), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.64 | 2.46 | 4.0 | |
| Quick ratio | 0.64 | 2.06 | 4.0 | |
| Debt to Equity | 0.26 | -0.13 | 8.0 | |
| Debt to Assets | 0.13 | 1.87 | 8.0 | |
| Interest coverage | N/A | 4.31 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -234K | -275K | -206K | -157K | -151K |
| Operating Income | -13M | -11M | -18M | -6M | -6M |
| Net Income | -13M | -10M | -12M | -7M | -7M |
| EBITDA | -13M | -10M | -18M | -6M | -6M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | 45.65 | 1.0 | |
| Operating margin % | N/A | -6.04 | 1.0 | |
| Net margin % | N/A | -69.12 | 1.0 | |
| EBITDA margin % | N/A | -45.92 | 1.0 | |
| Cash flow margin % | N/A | -185.04 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 50.88 | 5.5 |
| Next quarter | N/A | 60 | 5.5 |
| Current year | N/A | 60.36 | 5.5 |
| Next year | N/A | 14.12 | 4.5 |
| Weighted average score | 5.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 58.62 | 66.56 | 30.53 | 10 |
| Y/Y | 999 | -26.54 | 41.4 | 14.56 | 7.3 |
| 3y average | 999 | 16.07 | 82.54 | 26.21 | 9.8 |
| 5y average | 999 | 7.02 | 64.35 | 11.86 | 8.0 |
| Weighted average score | 8.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |